Efficacy News and Research

RSS
Applied Nanoscience in joint venture agreement to produce disposable protective face mask

Applied Nanoscience in joint venture agreement to produce disposable protective face mask

Physicians lack knowledge of off-label drug use and FDA approval status

Physicians lack knowledge of off-label drug use and FDA approval status

Study finds that vaccinations to schoolchildren and to their parents helps to control the spread of the seasonal flu and H1N1

Study finds that vaccinations to schoolchildren and to their parents helps to control the spread of the seasonal flu and H1N1

Bronchial asthma screening procedure for preschoolers still unreliable

Bronchial asthma screening procedure for preschoolers still unreliable

FDA permits Worldheart for bridge-to-transplant study of the Levacor Ventricular Assist Device

FDA permits Worldheart for bridge-to-transplant study of the Levacor Ventricular Assist Device

Advaxis awarded $210,000 for development of a dual antigen vaccine

Advaxis awarded $210,000 for development of a dual antigen vaccine

Peplin completes four-week enrolment phase for REGION-Ib trial

Peplin completes four-week enrolment phase for REGION-Ib trial

New strategy found to increase the efficacy of protein-based drugs

New strategy found to increase the efficacy of protein-based drugs

Eclipsemed collaborates with EndyMed Medical to market the FDA approved radio frequency device

Eclipsemed collaborates with EndyMed Medical to market the FDA approved radio frequency device

Research reveals effectiveness of carvedilol in preventing variceal hemorrhage

Research reveals effectiveness of carvedilol in preventing variceal hemorrhage

Valensa International's technology increases shelf-life and stability of astaxanthin

Valensa International's technology increases shelf-life and stability of astaxanthin

InterMune receives $20 million event payment from Roche for initiating the Phase 2b trial of RG7227/ ITMN-191

InterMune receives $20 million event payment from Roche for initiating the Phase 2b trial of RG7227/ ITMN-191

Imagenetix announces retail distribution of InflameAway Celadrin(R) gels for promoting joint health

Imagenetix announces retail distribution of InflameAway Celadrin(R) gels for promoting joint health

Cardiovascular Systems' revenues in fourth-quarter of 2009 increases to $15.7 million

Cardiovascular Systems' revenues in fourth-quarter of 2009 increases to $15.7 million

FDA approves Hiberix Haemophilus influenzae type b vaccine

FDA approves Hiberix Haemophilus influenzae type b vaccine

The Gambia introduces pneumococcal immunisation programme

The Gambia introduces pneumococcal immunisation programme

Light Sciences Oncology announces Phase 2 trial of Aptocine in Benign Prostatic Hyperplasia

Light Sciences Oncology announces Phase 2 trial of Aptocine in Benign Prostatic Hyperplasia

Gentium reports results from phase 3 trial of defibrotide for severe veno-occlusive disease

Gentium reports results from phase 3 trial of defibrotide for severe veno-occlusive disease

Norovirus controlled on cruise ship Marco Polo with vaporisation process by Activ8

Norovirus controlled on cruise ship Marco Polo with vaporisation process by Activ8

Light-activated delivery system enhances anti-tumour drug potency

Light-activated delivery system enhances anti-tumour drug potency

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.